Anzeige
Mehr »
Freitag, 22.05.2026 - Börsentäglich über 12.000 News
Am 24. Mai wird es explosiv: +40% Kursgewinn in 5 Tagen: Eskaliert diese Nasdaq-Aktie jetzt komplett?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQDS | ISIN: CNE1000031F4 | Ticker-Symbol: 5IR
Frankfurt
22.05.26 | 09:55
1,830 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA ISOTOPE & RADIATION CORPORATION Chart 1 Jahr
5-Tage-Chart
CHINA ISOTOPE & RADIATION CORPORATION 5-Tage-Chart

Aktuelle News zur CHINA ISOTOPE & RADIATION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CHINA ISOTOPE & RADIATION Aktie jetzt für 0€ handeln
08.05.CIRC (01763): VOLUNTARY ANNOUNCEMENT - CONTRACT ON SECONDARY STANDARDIZED NEUTRON DOSIMETRY LABORATORY PROJECT TECHNICAL SERVICE ENTERED INTO BY CNGT, ...2
22.04.CIRC (01763): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT3
22.04.CIRC (01763): 2025 ANNUAL REPORT1
28.03.China Isotope & Radiation Corporation Reveals Decline In Full Year Income-
27.03.CIRC (01763): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 20251
27.03.CIRC (01763): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025-
19.03.CIRC (01763): VOLUNTARY ANNOUNCEMENT - ENTERING INTO EQUITY TRANSFER AGREEMENT TO FURTHER EXPAND THE NON-DESTRUCTIVE TESTING BUSINESS LAYOUT-
17.03.CIRC (01763): DATE OF BOARD MEETING-
13.03.CIRC (01763): VOLUNTARY ANNOUNCEMENT - CIRC AND ITS SUBSIDIARY ZHONGHE HEADWAY ENTERED INTO STRATEGIC COOPERATION AGREEMENT WITH THE PEOPLE'S GOVERNMENT ...1
02.03.CIRC (01763): VOLUNTARY ANNOUNCEMENT - SELF-DEVELOPED 'RED BLOOD CELL LIFESPAN MEASUREMENT BREATH ANALYZER' OBTAINED CLASS II MEDICAL DEVICE REGISTRATION ...1
12.02.CIRC (01763): ANNOUNCEMENT - PROFIT WARNING-
09.01.CIRC (01763): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING3
31.12.25CIRC (01763): INSIDE INFORMATION - TAX-RELATED ISSUE INVOLVING A SUBSIDIARY1
19.12.25CIRC (01763): VOLUNTARY ANNOUNCEMENT - ZHONGHE HEADWAY, A SUBSIDIARY OF CIRC OBTAINED CLINICAL TRIAL APPROVAL FOR BNCT BORON DRUG-
18.12.25CIRC (01763): PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING-
18.12.25CIRC (01763): MAJOR AND CONTINUING CONNECTED TRANSACTIONS RENEWAL OF PRODUCTS AND SERVICES SUPPLY FRAMEWORK AGREEMENT RENEWAL OF PRODUCTS AND SERVICES ...-
18.12.25CIRC (01763): NOTICE OF EXTRAORDINARY GENERAL MEETING2
15.12.25CIRC (01763): INSIDE INFORMATION - ENTERING INTO A COMMERCIAL COOPERATION AGREEMENT WITH NOVARTIS PHARMA TECHNOLOGY (ZHEJIANG) CO., LTD.-
11.12.25CIRC (01763): CONTINUING CONNECTED TRANSACTIONS RENEWAL OF CONTINUING CONNECTED TRANSACTIONS2
27.11.25CIRC (01763): VOLUNTARY ANNOUNCEMENT - CIRC AND CNNC CAPITAL ENTERED INTO STRATEGIC COOPERATION AGREEMENT EMPOWERING HIGH-QUALITY DEVELOPMENT WITH FINANCIAL ...1
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1